• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN PROTEGE RX CAROTID STENT SYSTEM; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN PROTEGE RX CAROTID STENT SYSTEM; STENT, CAROTID Back to Search Results
Catalog Number SEPX-8-6-40-135
Device Problems Difficult to Remove (1528); Material Deformation (2976); Physical Resistance/Sticking (4012)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/29/2024
Event Type  Injury  
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
A physician was attempting to implant a protege rx stent in the patients right common carotid artery.Lesion exhibited 87% stenosis.There were no abnormalities reported in relation to anatomy.Physician used an 0.14 guidewire and a 5mm spider fx to reach about 5cm distal to the lesion, and used a 4-30 balloon with standard pressure to dilate.After dilation, physician prepared to implant the protégé rx stent. after opening the outer packaging of the stent, physician fully hydrated it and prepared to go up along the spider guidewire to the location of the lesion.The guidewire slowly entered the stent transporter from the tip end of the transporter, and the stent went upper along the guidewire to the location of the lesion.After all the stents were in place, physician used angiography to confirm the position of the stent again.After confirming the position, physician slowly deployed the stent.The stent was placed smoothly and remains implanted in patient, and the stent transporter was ready to be withdrawn.At the beginning, the withdrawal went smoothly, but suddenly encountered resistance.Physician repeatedly adjusted and rotated the transporter, but still could not withdraw smoothly.When withdrawing the transporter, physician found that the transporter caused the spider to slide down.After adjusting the transporter various angles and directions, it still could not be withdrawn.After trying for about 1 hour and 30 minutes, the surgeon changed the surgical strategy and used a react-71 catheter to go up through the far end of the stent, and withdrew the spider and transporter at the same time.Finally, the spider and transporter were successfully withdrawn, and careful observation found that the tip end of the transporter was broken.The physician determined that after the transporter was damaged, it was entangled with the spider guidewire, causing the transporter to be unable to be withdrawn smoothly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROTEGE RX CAROTID STENT SYSTEM
Type of Device
STENT, CAROTID
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key18985720
MDR Text Key338692119
Report Number2183870-2024-00107
Device Sequence Number1
Product Code NIM
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P060001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other
Type of Report Initial
Report Date 03/27/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/27/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberSEPX-8-6-40-135
Device Lot NumberB632506
Was Device Available for Evaluation? No
Date Manufacturer Received02/29/2024
Date Device Manufactured09/28/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
SPIDER FX EMBOLIC PROTECTION SYSTEM
Patient Outcome(s) Required Intervention;
Patient Age68 YR
Patient SexMale
-
-